JUN 23, 2020 6:03 AM PDT

Nanosponges Mop up Viruses to Treat COVID Infections

WRITTEN BY: Tara Fernandez

 

Scientists have developed an experimental therapy for COVID-19 that uses coated nanoparticles to intercept SARS-CoV-2 infection. A collaborative effort between researchers at the University of California San Diego and Boston University have recently released promising data in the journal Nano Letters — the first step in the sprint to bring the therapy to COVID-19 patients.

The core of the innovation consists of tiny particles that are enveloped in a coating of human lung and immune cell membranes. The team named their innovation “nanosponges” after their ability to bind to and remove viral pathogens, much like the cleaning action of a sponge. Nanosponges act as molecular decoys, hindering the ability of the SARS-CoV-2 virus to infect lung cells by up to 90 percent in lab-based assays.

Liangfang Zhang, a nanoengineering professor at the UC San Diego and corresponding author of the study, explains the rationale behind nanosponges: "Traditionally, drug developers for infectious diseases dive deep on the details of the pathogen in order to find druggable targets. Our approach is different. We only need to know what the target cells are. And then we aim to protect the targets by creating biomimetic decoys."

 

 

A closer look at the structure of nanosponges reveals a biodegradable polymer core, surrounded in a shell made up of membrane extracts from lung epithelial cells and macrophages. These membranes decorate the surface of the nanoparticles with the same receptors that SARS-CoV-2 uses to gain entry into human cells during infection. Once administered to COVID-19 patients, trillions of these minuscule particles flood the lungs, latch on to the virus rendering them inactive, and are subsequently cleared by the body’s immune cells.

Nanosponges have an edge over many COVID-19 treatments that specifically target SARS-CoV-2 as they can be used to treat a wide spectrum of viruses that infect the respiratory tract and are can continue to be effective even if SARS-CoV-2 mutates. On top of that, they can also be designed to mop up inflammatory cytokine proteins that are responsible for potentially lethal COVID-19 “cytokine storms”. 

Zhang and colleagues are racing to bring nanosponge technology to the clinic, saying, "For COVID-19, I hope other teams come up with safe and effective therapies and vaccines as soon as possible. At the same time, we are working and planning as if the world is counting on us."

 

Sources: Technology Networks, Nano Letters


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 19, 2020
Cell & Molecular Biology
Mild COVID-19 Cases Induce an Immune Cell Response
AUG 19, 2020
Mild COVID-19 Cases Induce an Immune Cell Response
As the pandemic virus, SARS-CoV-2 continues to cause tens of thousands of new cases of COVID-19 every day in the United ...
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 14, 2020
Microbiology
The Immune System Can Kill HIV with a Helper Molecule
SEP 14, 2020
The Immune System Can Kill HIV with a Helper Molecule
HIV attacks the human immune system's CD4 cells, a major player in the body's defense against pathogens.
SEP 21, 2020
Cell & Molecular Biology
The Hormones We Have at Birth Are Linked to Disease Throughout Life
SEP 21, 2020
The Hormones We Have at Birth Are Linked to Disease Throughout Life
New work may help explain why some autoimmune or immune-related diseases are more common in women, who are more likely t ...
OCT 01, 2020
Immunology
Immune Cells and MS: The Good, the Bad, and the Maybe
OCT 01, 2020
Immune Cells and MS: The Good, the Bad, and the Maybe
Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a sim ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
Loading Comments...